Sanofi (SNY) Total Debt Growth (5y) (2014 - 2025)
Sanofi (SNY) Total Debt Growth (5y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Sanofi | - | - | 9.49 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.22% |
| Jun 30, 2025 | -2.35% |
| Dec 31, 2024 | -8.95% |
| Jun 30, 2024 | -3.96% |
| Dec 31, 2023 | -8.91% |
| Dec 31, 2022 | 1.12% |
| Jun 30, 2022 | 0.02% |
| Dec 31, 2021 | 2.98% |
| Jun 30, 2021 | 327.78% |
| Dec 31, 2020 | 8.15% |
| Jun 30, 2020 | 9.93% |
| Dec 31, 2019 | 8.09% |
| Jun 30, 2019 | 7.14% |
| Dec 31, 2018 | 7.21% |
| Dec 31, 2017 | -0.51% |
| Jun 30, 2017 | -0.52% |
| Dec 31, 2016 | -0.73% |
| Jun 30, 2016 | -77.41% |
| Dec 31, 2015 | 243.35% |
| Jun 30, 2015 | 221.81% |